Legal & General Group Plc - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,187,534
+16.1%
43,249
+7.1%
0.00%0.0%
Q2 2023$1,884,595
+67.6%
40,364
+37.4%
0.00%
Q1 2023$1,124,347
+55.1%
29,387
+122.1%
0.00%
Q4 2022$724,948
+107.7%
13,229
+29.2%
0.00%
Q3 2022$349,000
+391.5%
10,236
+36.9%
0.00%
Q2 2022$71,000
-27.6%
7,478
+8.2%
0.00%
Q1 2022$98,000
-32.9%
6,9090.0%0.00%
Q4 2021$146,000
-4.6%
6,909
+0.6%
0.00%
Q3 2021$153,000
+64.5%
6,867
+81.7%
0.00%
Q2 2021$93,000
+34.8%
3,779
+60.3%
0.00%
Q1 2021$69,000
+9.5%
2,358
-3.0%
0.00%
Q4 2020$63,000
-16.0%
2,4300.0%0.00%
Q3 2020$75,000
+63.0%
2,430
+31.8%
0.00%
Q2 2020$46,000
+70.4%
1,844
+44.1%
0.00%
Q1 2020$27,000
+35.0%
1,280
+40.7%
0.00%
Q4 2019$20,000
+17.6%
910
+19.9%
0.00%
Q3 2019$17,0007590.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$169,134,00018.83%
venBio Partners LLC 2,444,311$70,909,0006.74%
Versant Venture Management, LLC 617,727$17,920,0003.49%
Redmile Group, LLC 2,513,746$72,924,0001.03%
Boxer Capital, LLC 831,495$24,122,0000.82%
Integral Health Asset Management, LLC 85,000$2,466,0000.70%
Vivo Capital, LLC 673,280$19,532,0000.69%
SILVERARC CAPITAL MANAGEMENT, LLC 32,000$928,0000.51%
Cormorant Asset Management, LP 742,549$21,541,0000.48%
HHLR ADVISORS, LTD. 1,656,673$48,060,0000.48%
View complete list of AKERO THERAPEUTICS INC shareholders